Please wait a minute...
浙江大学学报（医学版）
浙江大学学报（医学版）  2019, Vol. 48 Issue (5): 580-585    DOI: 10.3785/j.issn.1008-9292.2019.10.18
综述     
体外受精-胚胎移植中的经济学研究
井苗苗(),张润驹*()
浙江大学医学院附属妇产科医院生殖内分泌科, 浙江 杭州 310006
Economic studies of in vitro fertilization and embryo transfer
JING Miaomiao(),ZHANG Runju*()
Department of Reproductive Endocrinology, Women's Hospital, Zhejiang University School of Medicine, Hangzhou 310006, China
 全文: PDF(684 KB)   HTML( 7 )
摘要：

体外受精-胚胎移植（IVF-ET）技术是不孕症的主要治疗手段之一，但其操作过程复杂，费用昂贵，且在大多数发展中国家没有纳入社会医疗保险。因此，如何以最低的成本获取最大的成功率是临床医生和患者共同关心的问题。目前关于IVF-ET技术中的经济学研究主要集中在不同促排卵药物、不同促排卵方案、不同移植方式及移植个数等方面，但IVF-ET技术过程复杂，相关经济学研究方法多样，结局指标目前没有统一的标准，何种为更经济有效的方案也没有统一的定论。因此，分析IVF-ET技术中的经济学研究，探讨总结更合适的评价方法及更经济有效的方案，不仅可以合理分配医疗卫生资源，指导临床选择，还可以为今后IVF-ET治疗费用纳入医保提供重要的参考依据。
关键词： 胚胎移植/经济学;  体外受精/经济学;  经济学, 药学;  成本及成本分析;  费用效益分析    
Abstract:

In vitro fertilization and embryo transplantation (IVF-ET) technology is one of the main treatments for infertility. But IVF-ET is expensive and has not be covered by health insurance in most developing countries. Therefore, how to obtain the maximum success rate with the minimum cost is a common concern of clinicians and patients. At present, the economic studies on IVF-ET mainly focus on different ovulation stimulating drugs, different ovulation stimulating protocols, different transplantation methods and the number of transplants. But the process of IVF-ET is complex, the relevant methods of economic study are diverse, and there are no unified standard for outcome indicators, so there is no unified conclusion for more economical and effective protocol by now. Therefore, to analyze the economic studies of IVF-ET, and to explore appropriate evaluation methods and cost-effective protocols will be helpful for reasonable allocation of medical resources and guidance of clinical selection. It would provide policy reference to include the costs of IVF-ET treatment in health insurance in the future.
Key words: Embryo transfer/economics    Fertilization in vitro/economics    Economics, pharmaceutical    Costs and cost analysis    Cost-benefit analysis
收稿日期: 2019-03-20 出版日期: 2020-01-04
:  R19  
基金资助: 国家自然科学基金(81300464);浙江省医药卫生科技计划(2015128465)
通讯作者: 张润驹     E-mail: 21718431@zju.edu.cn;5311005@zju.edu.cn
作者简介: 井苗苗(1993-), 女, 硕士研究生, 主要从事辅助生殖药物经济学、生殖内分泌研究; E-mail:21718431@zju.edu.cn; https://orcid.org/0000-0002-7617-6833
服务　　
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章　　
井苗苗
张润驹

引用本文:

井苗苗,张润驹. 体外受精-胚胎移植中的经济学研究[J]. 浙江大学学报（医学版）, 2019, 48(5): 580-585.

JING Miaomiao,ZHANG Runju. Economic studies of in vitro fertilization and embryo transfer. J Zhejiang Univ (Med Sci), 2019, 48(5): 580-585.

链接本文:

http://www.zjujournals.com/med/CN/10.3785/j.issn.1008-9292.2019.10.18    或    http://www.zjujournals.com/med/CN/Y2019/V48/I5/580

1 MASCARENHAS M N, FLAXMAN S R, BOERMA T, et al. National, regional, and global trends in infertility prevalence since 1990: a systematic analysis of 277 health surveys[J/OL]. PLoS Med, 2012, 9(12): e1001356.
2 European Society of Human Reproduction and Embryology. More than 8 million babies born from IVF since the world's first in 1978[EB/OL]. https://www.cnn.com/2018/07/03/health/worldwide-ivf-babies-born-study/index.html.
3 OMBELET W , CAMPO R . Affordable IVF for developing countries[J]. Reprod Biomed Online, 2007, 15 (3): 257- 265
doi: 10.1016/S1472-6483(10)60337-9
4 吴久鸿 . 药物经济学[M]. 北京: 高等教育出版社, 2017: 3- 5
WU Jiuhong . Pharmacoeconomics[M]. Beijing: Higher Education Press, 2017: 3- 5
5 DAYA S , LEDGER W , AURAY J P et al. Cost-effectiveness modelling of recombinant FSH versus urinary FSH in assisted reproduction techniques in the UK[J]. Hum Reprod, 2001, 16 (12): 2563- 2569
doi: 10.1093/humrep/16.12.2563
6 SILVERBERG K , DAYA S , AURAY J P et al. Analysis of the cost effectiveness of recombinant versus urinary follicle-stimulating hormone in in vitro fertilization/intracytoplasmic sperm injection programs in the United States[J]. Fertil Steril, 2002, 77 (1): 107- 113
doi: 10.1016/S0015-0282(01)02945-4
7 ROMEU A , BALASCH J , RUIZ BALDA J A et al. Cost-effectiveness of recombinant versus urinary follicle-stimulating hormone in assisted reproduction techniques in the Spanish public health care system[J]. J Assist Reprod Genet, 2003, 20 (8): 294- 300
doi: 10.1023/A:1024899806149
8 DE MOUZON J , ALLAVENA E , SCHMITT C et al. In vitro fertilization in France: economic aspects and influence of the gonadotropin choice (urinary vs. recombinant) on cost[J]. Gynecol Obstet Fertil, 2004, 32 (6): 508- 518
doi: 10.1016/j.gyobfe.2004.05.002
9 WECHOWSKI J , CONNOLLY M , SCHNEIDER D et al. Cost-saving treatment strategies in in vitro fertilization: a combined economic evaluation of two large randomized clinical trials comparing highly purified human menopausal gonadotropin and recombinant follicle-stimulating hormone alpha[J]. Fertil Steril, 2009, 91 (4): 1067- 1076
doi: 10.1016/j.fertnstert.2008.01.034
10 BARRIERE P , PORCU-BUISSON G , HAMAMAH S . Cost-effectiveness analysis of the gonadotropin treatments HP-hMG and rFSH for assisted reproductive technology in France: a markov model analysis[J]. Appl Health Econ Health Policy, 2018, 16 (1): 65- 77
doi: 10.1007/s40258-017-0361-7
11 BAKER V L , FUJIMOTO V Y , KETTEL L M et al. Clinical efficacy of highly purified urinary FSH versus recombinant FSH in volunteers undergoing controlled ovarian stimulation for in vitro fertilization: a randomized, multicenter, investigator-blind trial[J]. Fertil Steril, 2009, 91 (4): 1005- 1011
doi: 10.1016/j.fertnstert.2008.01.064
12 PETANOVSKI Z , DIMITROV G , AYDIN B et al. Recombinant FSH versus HP-HMG for controled ovarian stimulation in intracitoplasmic sperm injection cycles[J]. Med Arh, 2011, 65 (3): 153- 156
doi: 10.5455/medarh.2011.65.153-156
13 XUE W , LLOYD A , FALLA E et al. A cost-effectiveness evaluation of the originator follitropin alpha compared to the biosimilars for assisted reproduction in Germany[J]. Int J Womens Health, 2019, 11 319- 331
doi: 10.2147/IJWH.S193048
14 季静娟, 骆丽华, 童先宏 et al. 微刺激方案治疗卵巢低反应IVF周期的疗效和经济学评价[J]. 生殖与避孕, 2009, 29 (11): 768- 771
JI Jingjuan , LUO Lihua , TONG Xianhong et al. Therapeutic efficiency and economic evaluation of minimal stimulation protocol in the treatment of ovarian poor responders[J]. Reproduction and Contraception, 2009, 29 (11): 768- 771
15 张佼.三种促排卵方案对卵巢储备功能低下患者促排卵疗效分析及卫生经济学比较[D].贵阳: 贵州医科大学, 2016.
ZHANG Jiao. Effect analysis and health economics comparison of three ovulation induction schemes on ovulation induction in patients with low ovarian reserve function[D]. Guiyang: Guizhou Medical University, 2016. (in Chinese)
16 陈潇, 耿玲, 李红 . 两种促排卵方案应用于重复周期患者的临床结局及卫生经济学比较[J]. 南方医科大学学报, 2014, 34 (4): 563- 567
CHEN Xiao , GENG Ling , LI Hong . Clinical outcomes and economic analysis of two ovulation induction protocols in patients undergoing repeated IVF/ICSIcycles[J]. Journal of Southern Medical University, 2014, 34 (4): 563- 567
doi: 10.3969/j.issn.1673-4254.2014.04.27
17 MANSOUR R , ABOULGHAR M , SEROUR G I et al. The use of clomiphene citrate/human menopausal gonadotrophins in conjunction with GnRH antagonist in an IVF/ICSI program is not a cost effective protocol[J]. Acta Obstet Gynecol Scand, 2003, 82 (1): 48- 52
doi: 10.1034/j.1600-0412.2003.820108.x
18 MALDONADO L G , FRANCO J G JR , SETTI A S et al. Cost-effectiveness comparison between pituitary down-regulation with a gonadotropin-releasing hormone agonist short regimen on alternate days and an antagonist protocol for assisted fertilization treatments[J]. Fertil Steril, 2013, 99 (6): 1615- 1622
doi: 10.1016/j.fertnstert.2013.01.095
19 PAN W, TU H, JIN L, et al. Decision analysis about the cost-effectiveness of different in vitro fertilization-embryo transfer protocol under considering governments, hospitals, and patient[J/OL]. Medicine (Baltimore), 2019, 98(19): e15492.
20 CHEN Z J , SHI Y , SUN Y et al. Fresh versus frozen embryos for infertility in the polycystic ovary syndrome[J]. N Engl J Med, 2016, 375 (6): 523- 533
doi: 10.1056/NEJMoa1513873
21 SHI Y , SUN Y , HAO C et al. Transfer of fresh versus frozen embryos in ovulatory women[J]. N Engl J Med, 2018, 378 (2): 126- 136
doi: 10.1056/NEJMoa1705334
22 MAHESHWARI A , PANDEY S , AMALRAJ RAJA E et al. Is frozen embryo transfer better for mothers and babies? Can cumulative meta-analysis provide a definitive answer?[J]. Hum Reprod Update, 2018, 24 (1): 35- 58
doi: 10.1093/humupd/dmx031
23 LE K D , VUONG L N , HO T M et al. A cost-effectiveness analysis of freeze-only or fresh embryo transfer in IVF of non-PCOS women[J]. Hum Reprod, 2018, 33 (10): 1907- 1914
doi: 10.1093/humrep/dey253
24 PAPALEO E , PAGLIARDINI L , VANNI V S et al. A direct healthcare cost analysis of the cryopreserved versus fresh transfer policy at the blastocyst stage[J]. Reprod Biomed Online, 2017, 34 (1): 19- 26
doi: 10.1016/j.rbmo.2016.09.008
25 MAHESHWARI A , BHATTACHARYA S , BOWLER U et al. Study protocol: E-freeze-freezing of embryos in assisted conception: a randomised controlled trial evaluating the clinical and cost effectiveness of a policy of freezing embryos followed by thawed frozen embryo transfer compared with a policy of fresh embryo transfer, in women undergoing in vitro fertilisation[J]. Reprod Health, 2019, 16 (1): 81
doi: 10.1186/s12978-019-0737-2
26 TIITINEN A , HALTTUNEN M , H?RKKI P et al. Elective single embryo transfer: the value of cryopreservation[J]. Hum Reprod, 2001, 16 (6): 1140- 1144
doi: 10.1093/humrep/16.6.1140
27 PANDIAN Z , MARJORIBANKS J , OZTURK O et al. Number of embryos for transfer following in vitro fertilisation or intra-cytoplasmic sperm injection[J]. Cochrane Database Syst Rev, 2013, (7): CD003416
28 VAN LOENDERSLOOT L L , MOOLENAAR L M , VAN WELY M et al. Cost-effectiveness of single versus double embryo transfer in IVF in relation to female age[J]. Eur J Obstet Gynecol Reprod Biol, 2017, 214 25- 30
doi: 10.1016/j.ejogrb.2017.04.031
29 HERNANDEZ TORRES E , NAVARRO-ESPIGARES J L , CLAVERO A et al. Economic evaluation of elective single-embryo transfer with subsequent single frozen embryo transfer in an in vitro fertilization/intracytoplasmic sperm injection program[J]. Fertil Steril, 2015, 103 (3): 699- 706
doi: 10.1016/j.fertnstert.2014.11.032
30 CHAMBERS G M , SULLIVAN E A , ISHIHARA O et al. The economic impact of assisted reproductive technology: a review of selected developed countries[J]. Fertil Steril, 2009, 91 (6): 2281- 2294
doi: 10.1016/j.fertnstert.2009.04.029
31 ESHRE Capri Workshop Group . Economic aspects of infertility care: a challenge for researchers and clinicians[J]. Hum Reprod, 2015, 30 (10): 2243- 2248
doi: 10.1093/humrep/dev163
[1] 邓璇,何寒青,周洋,潘金仁,严睿,唐学雯,符剑. 水痘疫苗不同免疫策略的卫生经济学评价[J]. 浙江大学学报（医学版）, 2018, 47(4): 374-380.
[2] 何斌 等. 贝伐珠单克隆抗体在难治性子宫颈癌中的应用进展[J]. 浙江大学学报（医学版）, 2016, 45(4): 395-402.
[3] . 含铋剂四联一线治疗方案根除幽门螺杆菌疗效观察[J]. 浙江大学学报（医学版）, 2011, 40(3): 327-331.